These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4396667)

  • 1. Antilipolytic activity of 4-(2-hydroxy-3-isopropylaminopropoxy) acetanilide (Practolol).
    Miller DW; Allen DO
    Proc Soc Exp Biol Med; 1971 Mar; 136(3):715-8. PubMed ID: 4396667
    [No Abstract]   [Full Text] [Related]  

  • 2. The action of practolol and propranolol on the rabbit isolated atrium.
    Wale J
    Eur J Pharmacol; 1970 Mar; 9(3):387-90. PubMed ID: 4392487
    [No Abstract]   [Full Text] [Related]  

  • 3. Blockade of cardiac effects of isoproterenol by 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide (ICI 50,172).
    Somani P; Laddu AR
    J Pharmacol Exp Ther; 1969 Nov; 170(1):72-8. PubMed ID: 4390814
    [No Abstract]   [Full Text] [Related]  

  • 4. Differentiation of mechanisms of the antilipolytic actions produced by alpha and beta adrenergic blocking agents.
    Hynie S; Krishna G; Brodie BB
    Pharmacology; 1969; 2(3):129-37. PubMed ID: 4390572
    [No Abstract]   [Full Text] [Related]  

  • 5. Independence of the effects of epinephrine, glucagon, and adrenocorticotropin on glucose utilization from those on lipolysis in isolated rat adipose cells.
    Blecher M; Merlino NS; Ro'Ane JT; Flynn PD
    J Biol Chem; 1969 Jul; 244(13):3423-9. PubMed ID: 4307449
    [No Abstract]   [Full Text] [Related]  

  • 6. Absence of central nervous system effects of practalol [ICI 50,172; 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide], a new adrenergic beta-receptor blocking drug.
    Estler CJ; Ammon HP
    J Pharm Pharmacol; 1969 Aug; 21(8):554-5. PubMed ID: 4389726
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of propranolol, oxprenolol, and practolol on denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br Heart J; 1971 Jul; 33(4):614-5. PubMed ID: 4397631
    [No Abstract]   [Full Text] [Related]  

  • 8. Stimulation of pentose cycle in the eccrine sweat gland by adrenergic drugs.
    Sato K
    Am J Physiol; 1973 May; 224(5):1149-54. PubMed ID: 4144766
    [No Abstract]   [Full Text] [Related]  

  • 9. [Selective beta-blocking action of practolol (ICI 50.172)].
    Novelli GP; Pagni E; Cortesini C; Pagliai P; Francini R
    Minerva Anestesiol; 1969 Dec; 35(12):1286-94. PubMed ID: 4394406
    [No Abstract]   [Full Text] [Related]  

  • 10. Relative blocking effectiveness of propranolol and of practalol [4-(2-hydroxy-3-isopropylaminopropoxy) acetanilide] on isoprenaline in beta-1 receptor mediated calorigenesis.
    Arnold A; McAuliff JP
    J Pharm Pharmacol; 1969 Sep; 21(9):624-5. PubMed ID: 4390346
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of five beta-adrenoceptor antagonists on the effect of isoprenaline and acetylcholine on human isolated smooth muscle.
    Hedges A; Turner P
    Br J Pharmacol; 1971 Feb; 41(2):426P-427P. PubMed ID: 4396707
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of adrenergic beta receptor blockaders on the circulation in cats].
    Greeff K; Köhler E
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(1):79-86. PubMed ID: 4397216
    [No Abstract]   [Full Text] [Related]  

  • 13. [Action mechanism of ACTH--with special reference to the significance of adrenergic agents].
    Matsukura S
    Nihon Naibunpi Gakkai Zasshi; 1970 Sep; 46(6):618-24. PubMed ID: 4394254
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of beta-adrenoceptor blocking compounds (propranolol, practolol and LB 46) on isoprenaline induced changes in regional blood flow in the rat.
    Debreczeni L; Fenyvesi T
    Br J Pharmacol; 1971 Feb; 41(2):171-6. PubMed ID: 4396701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the inhibition of glucose metabolism in isolated fat cells by beta-adrenergic blocking agents.
    Allen DO; Ashmore J
    Biochem Pharmacol; 1969 Jun; 18(6):1347-54. PubMed ID: 5799108
    [No Abstract]   [Full Text] [Related]  

  • 17. A potent beta-adrenoreceptor blocking drug: 4-(2-hydroxy-3-isopropylaminopropoxy)indole.
    Moore GE; O'Donnell SR
    J Pharm Pharmacol; 1970 Mar; 22(3):180-8. PubMed ID: 4399485
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective metabolic and cardiovascular beta receptor antagonism in the rat.
    Stanton HC
    Arch Int Pharmacodyn Ther; 1972 Apr; 196(2):246-58. PubMed ID: 4401080
    [No Abstract]   [Full Text] [Related]  

  • 19. Antagonism by beta-adrenoceptor blocking agents of the antianaphylactic effect of isoprenaline.
    Assem ES; Schild HO
    Br J Pharmacol; 1971 Aug; 42(4):620-30. PubMed ID: 4107257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic adenosine monophosphate in human adipose tissue.
    Tulloch BR; Vydelingum N; Galton DJ
    Proc R Soc Med; 1972 Sep; 65(9):790-2. PubMed ID: 4404403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.